Stephen I. Rennard
About
Stephen I. Rennard is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology.
According to data from OpenAlex, Stephen I. Rennard has authored 594 papers receiving a total of 35.7k indexed citations (citations by other indexed papers that have themselves been cited), including 393 papers in Pulmonary and Respiratory Medicine, 200 papers in Physiology and 99 papers in Molecular Biology. Recurrent topics in Stephen I. Rennard's work include Chronic Obstructive Pulmonary Disease (COPD) Research (259 papers), Asthma and respiratory diseases (153 papers) and Respiratory Support and Mechanisms (103 papers). Stephen I. Rennard is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (259 papers), Asthma and respiratory diseases (153 papers) and Respiratory Support and Mechanisms (103 papers). Stephen I. Rennard collaborates with scholars based in United States, United Kingdom and Japan. Stephen I. Rennard's co-authors include Ronald G. Crystal, George R. Martin, Jørgen Vestbo, Peter B. Bitterman, Pamela Gehron Robey, Peter M.A. Calverley, Àlvar Agustí, John R. Spurzem, Emiel F.�M. Wouters and David A. Lomas and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
In The Last Decade
Stephen I. Rennard
583 papers receiving 34.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Stephen I. Rennard United States | 93 | 20.5k | 12.3k | 6.9k | 2.7k | 2.5k | 594 | 35.7k | ||
| Serpil C. Erzurum United States | 81 | 10.2k 0.5× | 10.2k 0.8× | 5.8k 0.8× | 3.7k 1.3× | 1.3k 0.5× | 311 | 25.3k | ||
| Dirkje S. Postma Netherlands | 89 | 18.8k 0.9× | 16.6k 1.4× | 4.0k 0.6× | 3.5k 1.3× | 2.5k 1.0× | 592 | 31.2k | ||
| Klaus F. Rabe Germany | 91 | 25.9k 1.3× | 18.2k 1.5× | 4.6k 0.7× | 3.5k 1.3× | 2.1k 0.8× | 585 | 37.6k | ||
| Ian M. Adcock United Kingdom | 100 | 12.6k 0.6× | 13.1k 1.1× | 11.6k 1.7× | 8.6k 3.2× | 1.3k 0.5× | 645 | 36.4k | ||
| Werner Seeger Germany | 109 | 29.0k 1.4× | 7.1k 0.6× | 11.6k 1.7× | 5.8k 2.1× | 606 0.2× | 1.2k | 51.4k | ||
| Peter D. Paré Canada | 79 | 16.6k 0.8× | 10.7k 0.9× | 2.8k 0.4× | 1.9k 0.7× | 1.0k 0.4× | 374 | 23.5k | ||
| Peter G. Gibson Australia | 116 | 22.0k 1.1× | 29.2k 2.4× | 5.8k 0.8× | 7.6k 2.8× | 3.2k 1.3× | 1.0k | 53.2k | ||
| Clive Page United Kingdom | 71 | 6.7k 0.3× | 7.7k 0.6× | 4.8k 0.7× | 2.9k 1.1× | 1.5k 0.6× | 525 | 19.5k | ||
| Nikolaos G. Papadopoulos Greece | 64 | 4.8k 0.2× | 5.5k 0.4× | 7.1k 1.0× | 2.8k 1.0× | 4.4k 1.7× | 639 | 24.3k | ||
| Friedrich C. Luft Germany | 112 | 5.5k 0.3× | 8.8k 0.7× | 12.8k 1.9× | 4.7k 1.7× | 866 0.3× | 1.1k | 50.6k |
Countries citing papers authored by Stephen I. Rennard
Since
Specialization
Citations
This map shows the geographic impact of Stephen I. Rennard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen I. Rennard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen I. Rennard more than expected).
Fields of papers citing papers by Stephen I. Rennard
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Stephen I. Rennard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen I. Rennard. The network helps show where Stephen I. Rennard may publish in the future.
Co-authorship network of co-authors of Stephen I. Rennard
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen I. Rennard. A scholar is included among the top collaborators of Stephen I. Rennard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen I. Rennard. Stephen I. Rennard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Erion, Derek M., et al.. (2024). Editing Approaches to Treat Alpha-1 Antitrypsin Deficiency. CHEST Journal. 167(2). 444–452.
2.
Dai, Hongying, et al.. (2023). Racial and ethnic disparities in biomarkers of exposure and potential harm among U.S. adult exclusive e-cigarette users: 2013–2019. Drug and Alcohol Dependence. 252. 110984–110984.
3.
Yentes, Jennifer M., Wai-Yan Liu, Kuan Zhang, Eric J. Markvicka, & Stephen I. Rennard. (2022). Updated Perspectives on the Role of Biomechanics in COPD: Considerations for the Clinician. International Journal of COPD. Volume 17. 2653–2675.
4.
Ragland, M.F., Erin Austin, Kendra A. Young, et al.. (2020). <p>Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene<sup>®</sup> Study</p>. Clinical Epidemiology. Volume 12. 1171–1181.
5.
Celli, Bartolomé R., Kay Tetzlaff, Gerard J. Criner, et al.. (2016). The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool: Insights from the COPD Biomarker Qualification Consortium. American Journal of Respiratory and Critical Care Medicine. 194(12). 1483–1493.
6.
Jacobson, Sean, Katerina Kechris, Gregory L. Kinney, et al.. (2016). Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts. American Journal of Respiratory and Critical Care Medicine. 195(4). 473–481.
7.
Sieren, Jered, John D. Newell, R. Graham Barr, et al.. (2016). SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs. American Journal of Respiratory and Critical Care Medicine. 194(7). 794–806.
8.
Wells, J. Michael, Philip O’Reilly, Tomasz Szul, et al.. (2014). An Aberrant Leukotriene A4 Hydrolase–Proline-Glycine-Proline Pathway in the Pathogenesis of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 190(1). 51–61.
9.
Couper, David, Lisa M. LaVange, MeiLan K. Han, et al.. (2013). Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1. Thorax. 69(5). 492–495.
10.
Polkey, Michael I., Martijn A. Spruit, Lisa Edwards, et al.. (2012). Six-Minute-Walk Test in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 187(4). 382–386.
11.
Celli, Bartolomé R., Nicholas Locantore, Julie Yates, et al.. (2012). Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 185(10). 1065–1072.
12.
Wan, Emily S., Weiliang Qiu, Andrea Baccarelli, et al.. (2012). Systemic Steroid Exposure Is Associated with Differential Methylation in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 186(12). 1248–1255.
13.
Kerwin, Edward, Stephen I. Rennard, Arthur F. Gelb, et al.. (2011). ACCORD COPD I: Improvements in nighttime symptoms and rescue medication use in COPD with twice-daily aclidinium bromide. European Respiratory Journal. 38(Suppl 55). p873–p873.
14.
Hanania, Nicola A., Hana Müllerová, Nicholas Locantore, et al.. (2010). Determinants of Depression in the ECLIPSE Chronic Obstructive Pulmonary Disease Cohort. American Journal of Respiratory and Critical Care Medicine. 183(5). 604–611.
15.
Togo, Shinsaku, Olaf Holz, Xiangde Liu, et al.. (2008). Lung Fibroblast Repair Functions in Patients with Chronic Obstructive Pulmonary Disease Are Altered by Multiple Mechanisms. American Journal of Respiratory and Critical Care Medicine. 178(3). 248–260.
16.
Rennard, Stephen I., Wayne H. Anderson, Richard ZuWallack, et al.. (2001). Use of a Long-acting Inhaled β2-Adrenergic Agonist, Salmeterol Xinafoate, in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 163(5). 1087–1092.
17.
Wyatt, Todd A., et al.. (2000). Acetaldehyde‐Stimulated PKC Activity in Airway Epithelial Cells Treated with Smoke Extract from Normal and Smokeless Cigarettes. Proceedings of The Society for Experimental Biology and Medicine. 225(1). 91–97.
18.
Fujita, Jiro, C. Magnus Sköld, David M. Daughton, et al.. (1999). Modulation of Elastase Binding to Elastin by Human Alveolar Macrophage–derived Lipids. American Journal of Respiratory and Critical Care Medicine. 160(3). 802–807.
19.
Rennard, Stephen I.. (1999). Inflammation and Repair Processes in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 160(Supplement_1). S12–S16.
20.
Sköld, C. Magnus, Xiangde Liu, Takeshi Umino, et al.. (1999). Human Neutrophil Elastase Augments Fibroblast-Mediated Contraction of Released Collagen Gels. American Journal of Respiratory and Critical Care Medicine. 159(4). 1138–1146.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Serpil C. Erzurum Breakdown of academic impact, for papers by Dirkje S. Postma Breakdown of academic impact, for papers by Klaus F. Rabe Breakdown of academic impact, for papers by Ian M. Adcock Breakdown of academic impact, for papers by Werner Seeger Breakdown of academic impact, for papers by Peter D. Paré Breakdown of academic impact, for papers by Peter G. Gibson Breakdown of academic impact, for papers by Clive Page Breakdown of academic impact, for papers by Nikolaos G. Papadopoulos Breakdown of academic impact, for papers by Friedrich C. Luft